FDA's Peptide Review Sparks Bigger Questions on Health Regulation The FDA has initiated a review of restrictions on peptides, highlighting broader issues with regulating the multibillion dollar health supplements and pharmaceuticals industry.
While the agency's efforts aim to ensure public safety, they also underscore the need for more effective oversight.
Peptides, often derived from amino acids, have gained popularity among athletes and health enthusiasts as muscle building aids and anti aging treatments.